TITLE:
Prevention Of Recurrence Of Atrial Fibrillation

CONDITION:
Fibrillation, Atrial

INTERVENTION:
SB-207266

SUMMARY:

      The purpose of this study is to determine whether the study drug is effective in preventing
      the recurrence of atrial fibrillation (an abnormal heart rhythm).
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Symptomatic persistent atrial fibrillation requiring DC cardioversion.

          -  Duration of AF >48 hrs. <6 months

        Exclusion Criteria:

          -  Concomitant Class I and/or III anti-arrhythmic drugs.

          -  Amiodarone treatment within 3 months of the study.

          -  Other inclusion or exclusion criteria to be determined by the physician and study
             sponsor.
      
